XTANDI is approved to treat 4 types* of advanced prostate cancer

Learn about these 4 types

*metastatic castration sensitive prostate cancer (mCSPC); non-metastatic castration sensitive prostate cancer with high risk of cancer spreading (nmCSPC high-risk BCR); metastatic castration resistant prostate cancer (mCRPC); non-metastatic castration resistant prostate cancer (nmCRPC)

Patient with family member

Real patients. Real XTANDI Xperiences.

Gain perspectives into the lives of men living with prostate cancer and their family.

DOCTOR DISCUSSION GUIDE

Bring this guide to your next doctor's appointment

Take charge of your care. This guide is full of questions to ask your doctor about prostate cancer and XTANDI.

Get the guide
Icon: Prostate cancer patient discussing XTANDI® with his doctor

Select Safety Information

XTANDI may cause serious side effects including seizure. If you take XTANDI, you may be at risk of having a seizure. Avoid activities where a sudden loss of consciousness could seriously harm you or someone else. Tell your doctor right away if you lose consciousness or have a seizure. Learn more

Sign up for support emails and resources

Sign up for
support

We’re here for you with tools, tips, helpful information, and resources.

Sign up

For more information on Financial Support, please call 1-855-898-2634